Biofourmis

Boston, United States

Biofourmis is a biotechnology company that develops healthcare technology platforms for monitoring patients at home.

$20.0M raised

Jul 2022

Series D

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Biofourmis raised?

Biofourmis has raised $20.0M in total funding. The most recent round was Series D. The last funding was announced in July 2022.

Who are Biofourmis's investors?

Biofourmis's investors include General Atlantic, Sequoia Capital, Peak XV Partners, CVS Health, Intel Capital.

Where is Biofourmis headquartered?

Biofourmis is headquartered in Boston, United States.

What does Biofourmis do?

Biofourmis is a biotechnology company that develops healthcare technology platforms for monitoring patients at home.

What stage is Biofourmis at?

Biofourmis is at the Series D stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated July 27, 2022.

MLA

"Biofourmis — Funding & Investors." VCBacked, July 27, 2022, https://www.vcbacked.co/company/biofourmis. Accessed July 1, 2026.

APA

VCBacked. (2022). Biofourmis — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/biofourmis

Wikipedia (cite web)

{{cite web |title=Biofourmis — Funding & Investors |url=https://www.vcbacked.co/company/biofourmis |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated July 27, 2022.